Antoinette Paone - 10 Feb 2022 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Jennifer Elliott, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 15:10:12 UTC
Next filing
19 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Stock Option (right to buy) Award $0 +110,000 $0.000000 110,000 10 Feb 2022 Common Stock 110,000 $5.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 10, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on February 10, 2023 and the remaining shares vesting in equal quarterly installments thereafter.